Buy ozempic semaglutide injection
What is Ozempic (semaglutide) for?
ozempic semaglutide injection is a medicine prescribed for the treatment of adult patients with type 2 diabetes mellitus. Although in recent years Ozempic has been often prescribed “off-label” for weight loss, it is not currently approved for this indication. 
 
 Ozempic (semaglutide) is available as a single-patient-use pen for subcutaneous injection in the following strengths:
2 mg/3 mL, delivering 0.25 mg or 0.5 mg per injection;
4 mg/3 mL, delivering 1 mg per injection;
8 mg/3 mL, delivering 2 mg per injection. 
 
How does Ozempic (semaglutide) work?
The active ingredient in Ozempic, semaglutide, is a GLP-1 receptor antagonist. It acts the same way as GLP-1 (a hormone produced in the gut). By increasing the amount of insulin released by the pancreas in response to food, semaglutide helps control blood glucose levels.
 
Where has Ozempic (semaglutide) been approved?
Ozempic (semaglutide) is currently approved in the USA, EU, Canada, Japan, and Australia for the treatment of type 2 diabetes. 
 
Ozempic FDA Approval History
FDA Approved: Yes (First approved December 5, 2017)
Brand name: Ozempic
Generic name: semaglutide
Dosage form: Injection
Company: Novo Nordisk
Treatment for: Diabetes, Type 2, Cardiovascular Risk Reduction
 
Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) analog for the treatment type 2 diabetes, and to reduce the risk of major cardiovascular events in patients with type 2 diabetes and known heart disease.
 
Ozempic is indicated as:
an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease.